×

Warning

JUser: :_load: Unable to load user with ID: 147359

The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study included about 800 older men with low testosterone and symptoms associated with this ailment, like http://tinyurl.com/jkhvqy9 sexual and physical dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.

The recent contradictory findings on testosterone therapy prompted his team to run a large systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among men and Patel. An estimated 13 million men in the USA suffer with low testosterone, which occurs when the body doesn't make enough hormones as a result of a problem with the testicles or pituitary gland. This describes an individual's unexpected weight gain, clear aging and decline of energy.

No clear lower limit of testosterone has been confirmed; nevertheless 15 ng per dL (0.5 nmol per L) typically is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had noticeably decreased sexual desire in all scenarios and absent or markedly decreased orgasms. Due to studies like this, supplemented with anecdotal evidence, many women are started on testosterone treatment. Most women can expect to spend one third of their lives in the postmenopausal stage. Depression, anger, moodiness, insomnia, and lack of well-being are common criticisms of postmenopausal women.